Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study Comparing Quality of Life in Patients with Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

Recruiting

Conditions: Lymphedema

Interventions: Behavioral: Quality of Life Assessments

First Posted Date: 2017-08-14

Last Posted Date: 2025-01-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 600

Registration Number: NCT03248310

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), West Harrison, New York, United States

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

Phase 1

Active, not recruiting

Conditions: Pancreatic Adenocarcinoma

Interventions: Drug: Durvalumab
Radiation: Stereotactic Ablative Body Radiotherapy (SABR)

First Posted Date: 2017-08-10

Last Posted Date: 2024-10-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT03245541

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

and more 4 locations

A Study of Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer

Phase 1

Active, not recruiting

Conditions: High Grade Serous Ovarian
Fallopian Tube
Primary Peritoneal Cancer

Interventions: Drug: Carboplatin and Paclitaxel
Drug: Nivolumab
Procedure: Cytoreductive surgery
Drug: Ipilimumab

First Posted Date: 2017-08-10

Last Posted Date: 2024-09-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT03245892

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Nivolumab in Selected Uterine Cancer Patients

Phase 2

Completed

Conditions: Uterine Cancer
Clear Cell Carcinoma
Endometrial Carcinoma
Carcinosarcoma
Leiomyosarcoma
Undifferentiated Sarcoma
High Grade Endometrial Stromal Sarcoma

Interventions: Drug: Nivolumab

First Posted Date: 2017-08-07

Last Posted Date: 2024-12-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 35

Registration Number: NCT03241745

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 5 locations

Pembrolizumab (immunotherapy Drug) in Combination with Guadecitabine and Mocetinostat (epigenetic Drugs) for Patients with Advanced Lung Cancer.

Phase 1

Active, not recruiting

Conditions: Lung Cancer

Interventions: Drug: Pembrolizumab
Drug: Guadecitabine
Drug: Mocetinostat

First Posted Date: 2017-07-18

Last Posted Date: 2024-12-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT03220477

Locations: 🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase 2

Active, not recruiting

Conditions: Brain Tumor

Interventions: Drug: abemaciclib

First Posted Date: 2017-07-18

Last Posted Date: 2024-07-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 64

Registration Number: NCT03220646

Locations: 🇺🇸
Lehigh Valley Health Network, Allentown, Pennsylvania, United States
🇺🇸
Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only), Hartford, Connecticut, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

and more 5 locations

Proton Re-Irradiation for Recurrent Head and Neck Cancer

Phase 2

Active, not recruiting

Conditions: Head and Neck Cancer

Interventions: Radiation: hypofractionated palliative re-irradiation
Radiation: conventionally fractionated full dose re-irradiation

First Posted Date: 2017-07-14

Last Posted Date: 2024-12-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 87

Registration Number: NCT03217188

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Baptist Alliance MCI, Miami, Florida, United States

and more 6 locations

RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers

Early Phase 1

Active, not recruiting

Conditions: Thyroid Cancer

Interventions: Drug: Durvalumab (Medi4736)
Radiation: Radioiodine (RAI)

First Posted Date: 2017-07-12

Last Posted Date: 2024-07-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 11

Registration Number: NCT03215095

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 4 locations

Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination

Not Applicable

Active, not recruiting

Conditions: Parents

Interventions: Behavioral: HPV Vaccine Education
Behavioral: Text Messaging Reminder

First Posted Date: 2017-07-06

Last Posted Date: 2024-04-17

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 672

Registration Number: NCT03209713

Locations: 🇺🇸
Research, Education and Access to Community Health (REACH), Las Vegas, Nevada, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
The University of Texas at El Paso, El Paso, Texas, United States

and more 1 locations

Understanding the Late Effects of Surviving a Pediatric Brain Tumor

Active, not recruiting

Conditions: Brain Tumor
Pediatric Cancer
Pediatric Brain Tumor

Interventions: Diagnostic Test: Diffusion tensor imaging (DTI)
Diagnostic Test: Resting state functional connectivity MRI (rs-fcMRI)
Behavioral: Wechsler Intelligence Scale for Children - 5th edition (WISC-V)
Behavioral: California Verbal Learning Test (CVLT-C)
Behavioral: Beery Test of Visual Motor Integration 6th edition
Behavioral: PedsQL Multidimensional Fatigue Scale
Behavioral: Grooved Pegboard
Diagnostic Test: MRI

First Posted Date: 2017-07-05

Last Posted Date: 2024-07-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 42

Registration Number: NCT03208387

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States

and more 1 locations

Home Terms & Conditions Privacy Policy